Sicart Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.93M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $403K | Hold |
|
|||||
|
2023
Q4 | $368K | Hold |
|
|||||
|
2023
Q3 | $345K | Hold |
|
|||||
|
2023
Q2 | $301K | Sell |
|
|||||
|
2023
Q1 | $384K | Sell |
|
|||||
|
2022
Q4 | $339K | Hold |
|
|||||
|
2022
Q3 | $324K | Sell |
|
|||||
|
2022
Q2 | $311K | Sell |
|
|||||
|
2022
Q1 | $376K | Sell |
|
|||||
|
2021
Q4 | $591K | Sell |
|
|||||
|
2021
Q3 | $634K | Sell |
|
|||||
|
2021
Q2 | $594K | Hold |
|
|||||
|
2021
Q1 | $503K | Buy |
|